Study of REGN6569 and Cemiplimab in Adult Patients with Advanced Solid Tumor Malignancies

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-500868-36-00

Acronym

R6569-ONC-1933

Enrollment

Registered

2024-09-03

Start date

2021-08-11

Completion date

2025-02-07

Last updated

2024-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Squamous Cell Carcinoma of Head and Neck

None listed

Sex/Gender

All

Age

18 Years to No maximum

Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026